Pharmaceutical Tamoxifen , Nolvadex For Tumor · Metastatic Breast Cancer Cas No. 54965-24-1
|Place of Origin:||China|
Payment & Shipping Terms:
|Minimum Order Quantity:||10vail|
|Packaging Details:||naked or custom-made|
|Delivery Time:||Within 7 working days|
|Payment Terms:||L/C, D/A, D/P, T/T, Western Union, MoneyGram,|
|Minimum Order Quantity:||1 Box||Packaging Details:||0.1mg/vial 1mg/vail|
|Purity:||99.8%||Delivery Time:||Within 7 Working Days|
|Payment Terms:||L/C, T/T, Western Union, MoneyGram,Alipay||Supply Ability:||100000vials/month|
peptides supplements bodybuilding,
muscle building supplements
GMP Lab Supply Igf-1lr3 Polypeptide Igf-1lr3 for Muscle Growth
|Specification||0.1mg/vial or 1mg/vial|
|Supply Ability||1000 kits per Month|
|Packing||10vials per kit|
|Appearance||White lyophilized powder|
What is the dosage for IGF-1LR3 ? Dose per injection: 50 mcg Injections per vial: 20 x 50 mcg dosages Example Amounts to Inject: If you use 1 ml of water for mixing then a 50mcg dosage = 0.05 ml (or 5 units on Insulin Syringe). For 2 ml of water for mixing then 50mcg = 0.10ml (or 10 units); if you have used 3ml of water for mixing, then 50mcg = 0.15ml (or 15 units).
IGF-1LR3 has a half-life of about 20-30 hours and is much more potent than base IGF-1. Since its half-life is about a day, the IGF-1LR3 will circulate the body, for around 24 hours, binding to receptors and activating cell communication that improves muscle growth and fat loss.
LR3 prevents glucose from entering into cells, which, in turn, forces the body to burn fat and not sucrose. In addition, its long half-life is desirable for another reason; site injections aren't necessary, as IGF-1LR3 will cycle the body binding to all muscle cells for about a day.
- enlarged amino acid transporting cells
- increased protein production
- reduced protein degradation
- amplified glucose transporting
- augmented RNA combination
As Peptides and Steroids manufacturer,we are for OEM for clients who have Brands Requirements.(Custom-made Service).
Our Company Services: